Cargando…
What’s New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity
Autores principales: | Hejal, Rana, Popa, Andrea, Rangel, Maribel Llamas, Remy, Kenneth E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401556/ https://www.ncbi.nlm.nih.gov/pubmed/37547191 http://dx.doi.org/10.4103/ijciis.ijciis_25_23 |
Ejemplares similares
-
What’s New in Critical Illness and Injury Science? Delirium, COVID-19, and critical illness
por: Miller, Andrew C.
Publicado: (2022) -
Retrospective evaluation of dexmedetomidine dosing in a cohort of neurologically injured obese critically ill patients
por: He, Harrison, et al.
Publicado: (2023) -
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
por: Iirola, Timo, et al.
Publicado: (2011) -
Weighing risks and benefits of stress ulcer prophylaxis in critically ill patients
por: Chanpura, Trupesh, et al.
Publicado: (2012) -
Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
por: Välitalo, Pyry Antti, et al.
Publicado: (2013)